Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYSEngine Precision Medicine’s PARIS® Test Identifies Novel Drug Combinations for PARP Inhibitor Resistant Ovarian Cancer in Study Published in EBioMedicinePREV STORYTheranostics: Global Markets